Partnering & Outsourcing Editorial
-
Contracting For AI In Clinical Trials: Cybersecurity, Monitoring, And Risk Allocation (Part 3)
5/15/2026
Leibowitz Law shares the third installment of its three-part series on contracting for AI in clinical trial operations. Part 3 picks up with cybersecurity, monitoring and validation, and risk allocation.
-
Contracting For AI In Clinical Trials: Data Rights And Regulatory Compliance (Part 2)
5/15/2026
Leibowitz Law's three-part series examines how AI is being used in clinical trial operations and the contractual and operational risks that follow. Part 2 demonstrates why organizations must understand where it is used, how it interacts with data, and where the risks lie.
-
Where AI Appears In Clinical Trials — And Why Contracts Need To Catch Up (Part 1)
5/15/2026
Leibowitz Law's three-part series examines how AI is being used in clinical trial operations and the contractual and operational risks that follow. Part 1 outlines where AI appears in ClinOps and supporting technologies, and the questions companies and organizations should ask when AI touches data.
-
What Sites, Sponsors, Vendors, And CROs Can All Agree On
4/17/2026
Experts representing sponsors, sites, vendors, and CROS discussed at Life Sciences Future SW the pain points and the opportunities that lie ahead in clinical research.
-
Lessons Learned While Taking Glioblastoma Drug From Bench To Clinic
4/9/2026
MimiVax CEO Mike Ciesielski recounts the company's transition from academia to industry, hitting on topics like vendor partnerships, FDA conversations, and manufacturer selection.
-
What To Look For In Rare Disease Partnerships, With Origami's Beth Hoffman
3/17/2026
Origami Therapeutics CEO Beth Hoffman shares how the company took both a measured and a gut-feeling approach to finding the right partner to supports its development of protein degraders for neurodegenerative diseases.
-
Avoid Clinical Alignment Breakdowns With "Lateral Agility"
3/6/2026
Internal misalignment can stall the clinical timeline, erode the window of patent protection, and jeopardize funding. Learn why leadership can no longer be and instead must exhibit "lateral agility" across the enterprise.
-
Outsourcing? When Both Sides Of The Table Are Investor-Backed, Everything Changes
3/6/2026
The outsourcing relationship is increasingly not sponsor versus provider. It is two investor-backed organizations navigating parallel pressures — with a shared program sitting in the middle.
-
The Cost Of Transactional Thinking In Clinical Research
2/26/2026
Denise N. Bronner of Empactful Ventures explores the power dynamics at play in clinical research, picking apart the roles of sponsors, vendors, and sites and advocating for a better way to do business among them.
-
When AI Meets Accounting: AI Costs And Intangible Asset Treatment For Sponsors And CROs
2/13/2026
Learn how to account for AI-related costs under evolving U.S. Generally Accepted Accounting Principles (GAAP).